Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Amortization of Deferred Charges (2020 - 2023)

Journey Medical filings provide 4 years of Amortization of Deferred Charges readings, the most recent being $177000.0 for Q3 2023.

  • On a quarterly basis, Amortization of Deferred Charges fell 11.94% to $177000.0 in Q3 2023 year-over-year; TTM through Dec 2023 was $353000.0, a 54.16% decrease, with the full-year FY2023 number at $353000.0, down 54.16% from a year prior.
  • Amortization of Deferred Charges hit $177000.0 in Q3 2023 for Journey Medical, up from $78000.0 in the prior quarter.
  • In the past five years, Amortization of Deferred Charges ranged from a high of $804000.0 in Q2 2021 to a low of -$409000.0 in Q3 2021.
  • Median Amortization of Deferred Charges over the past 4 years was $189000.0 (2022), compared with a mean of $175833.3.
  • The widest YoY moves for Amortization of Deferred Charges: up 149.14% in 2022, down 73.26% in 2022.
  • Journey Medical's Amortization of Deferred Charges stood at $206000.0 in 2020, then fell by 19.9% to $165000.0 in 2021, then dropped by 8.48% to $151000.0 in 2022, then grew by 17.22% to $177000.0 in 2023.
  • The last three reported values for Amortization of Deferred Charges were $177000.0 (Q3 2023), $78000.0 (Q2 2023), and $98000.0 (Q1 2023) per Business Quant data.